This week we are once again providing an update on the most recent drug shortages noting 75 products as being unavailable. Some of these shortages are short term, or limited availability, while others are completely unavailable with unknown release dates.
Learn how ophthalmology ASCs can safely navigate the trypan blue shortage using pharmacist-led strategies, clinical alternatives, and conservation best practices.
Another year has flown by. Unbelievably, we are quickly approaching 2026 and it’s time to look back at the biggest topics of 2025.
The FDA’s 2025 update on tranexamic acid strengthens safety warnings for IV-only use and mandates new labeling. Learn how OctariusRx helps ASCs stay compliant and enhance medication safety.
Happy National Pharmacy Week to all our team members and colleagues!
This week we are once again providing an update on the most recent drug shortages noting 77 products as being unavailable. Some of these shortages are short term, or limited availability, while others are completely unavailable with unknown release dates.
FDA requires opioid manufacturers to update prescribing information
Preview the new medications of 2025, as we reach the halfway point of the year. In this post, we look at the most recent approvals to keep you informed and help you keep your patients safe.
This week we are once again providing an update on the most recent drug shortages.
